Reider Paul

Reider Paul is listed in filings as Chief Commercial Officer at Coherus Oncology, Inc.. This profile follows SEC Form 4 activity through Jan 22, 2025, including 5 public disclosures. Recent filings connect the profile to Coherus Oncology, Inc. (CHRS). The current snapshot covers public activity from Jul 24, 2024 to Jan 22, 2025. Reported amounts are shown as $6.8K to $265.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.